iRadimed Corporation (IRMD) financial statements (2021 and earlier)

Company profile

Business Address 1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments463426262717
Cash and cash equivalents43281818199
Short-term investments368888
Receivables744442
Inventory, net of allowances, customer advances and progress billings444422
Inventory444422
Prepaid expense110000
Deferred tax assets  000
Other undisclosed current assets011000
Total current assets:594535343422
Noncurrent Assets
Property, plant and equipment222111
Intangible assets, net (including goodwill)111100
Intangible assets, net (excluding goodwill)111100
Other noncurrent assets000000
Other undisclosed noncurrent assets511000
Total noncurrent assets:844311
TOTAL ASSETS:674839373523
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities432322
Accounts payable111111
Accrued liabilities000000
Employee-related liabilities222111
Taxes payable100000
Deferred revenue and credits2110
Contract with customer, liability22
Other liabilities0000  
Other undisclosed current liabilities0     
Total current liabilities:654432
Noncurrent Liabilities
Liabilities, other than long-term debt322200
Deferred revenue and credits2200
Contract with customer, liability32
Other undisclosed noncurrent liabilities3     
Total noncurrent liabilities:522200
Total liabilities:1166532
Stockholders' equity
Stockholders' equity attributable to parent564233323221
Common stock000000
Additional paid in capital191513121916
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)(0)
Retained earnings36272020135
Total stockholders' equity:564233323221
TOTAL LIABILITIES AND EQUITY:674839373523

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues393023323216
Cost of revenue(9)(7)(6)(6)(6)(3)
Gross profit:302318262612
Operating expenses(21)(17)(16)(15)(14)(9)
Operating income:96111123
Nonoperating income (expense)00000(0)
Investment income, nonoperating00000 
Foreign currency transaction gain (loss), before tax(0)(0)(0)(0)(0)0
Income from continuing operations before income taxes:96111123
Income tax expense (benefit)10(1)(4)(4)(1)
Net income available to common stockholders, diluted:1060782

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:1060782
Other comprehensive income (loss)00(0)0(0)(0)
Comprehensive income, net of tax, attributable to parent:1060772

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: